Breaking News

Close

Ocuphire Pharma Inc (REXN)

Add to/Remove from Watchlist Add to Watchlist

Ocuphire Pharma historical data, for real-time data please try another search

1.810 0.000 0.00%

05/11 - Closed. Currency in USD ( Disclaimer )

Type: Equity

Market: United States

Volume: 0
Bid/Ask: 1.720 / 1.920
Day's Range: 1.720 - 1.920

Discussions
Recent Sentiments
User Rankings

REXN Recent Sentiments

This page contains information on users’ sentiments for the Ocuphire Pharma Inc stock, which are displayed both on charts of different periods of time and on a detailed table.

Start Date	Username	Call	Open Rate	End Date	Chg. %
Nov 02, 2020	дум дум		1.820	Nov 02, 2020 @ 1.840	+1.10%
Nov 02, 2020	재민 송		29.120	Nov 27, 2020 @ 1.810	-75.14%
Sep 16, 2020	Sayed Gomaa El Atafy		1.970	Oct 09, 2020 @ 2.120	+7.61%
Sep 02, 2020	Andreas Schatz		1.900	Sep 25, 2020 @ 2.250	+18.42%
Jun 09, 2020	Merrill Lynch		2.550	Jul 03, 2020 @ 2.850	+11.76%
Mar 31, 2020	zaime cp		1.850	Apr 24, 2020 @ 1.790	-3.24%
Feb 13, 2020	Merrill Lynch		3.200	Mar 06, 2020 @ 2.220	-30.62%
Feb 11, 2020	Adam Chams		3.780	Mar 06, 2020 @ 2.220	-41.27%
Feb 11, 2020	manu patehi		3.680	Mar 06, 2020 @ 2.220	-39.67%
Feb 11, 2020	Julián González...		3.420	Mar 06, 2020 @ 2.220	-35.09%
Feb 11, 2020	Zakarias Qfvarnström		3.730	Mar 06, 2020 @ 2.220	-40.48%
Feb 11, 2020	Daniel James		4.000	Mar 06, 2020 @ 2.220	-44.50%
Feb 11, 2020	damiano bonsaver		3.975	Mar 06, 2020 @ 2.220	+44.15%
Feb 11, 2020	Ron Maahpatha		3.720	Feb 13, 2020 @ 3.150	-15.32%
Feb 11, 2020	Shalauddin Mohammed		2.670	Mar 06, 2020 @ 2.220	-16.85%
Feb 11, 2020	davide garulli		2.250	Mar 06, 2020 @ 2.220	+1.33%
Feb 11, 2020	Ivica Maurovic		2.040	Feb 11, 2020 @ 2.700	+32.35%
Jan 02, 2020	MARIO LAYNA		2.000	Jan 08, 2020 @ 2.120	-6.00%
Nov 01, 2019	Chetan Woodun		2.440	Nov 22, 2019 @ 2.020	-17.21%
Nov 01, 2019	케이 딕		2.430	Nov 22, 2019 @ 2.020	+16.87%
Sep 24, 2019	기철 안		2.550	Sep 24, 2019 @ 2.530	+0.78%
Sep 06, 2019	keras kuip		2.450	Sep 27, 2019 @ 2.190	-10.61%
Jul 09, 2019	기철 안		5.507	Jul 09, 2019 @ 5.770	+4.78%
Jun 24, 2019	Gabriele Tripodo		5.490	Jul 19, 2019 @ 5.280	-3.83%
Jun 20, 2019	김 선일		5.340	Jul 12, 2019 @ 5.550	+3.93%
Jun 17, 2019	현재 최		5.240	Jul 12, 2019 @ 5.550	+5.92%
Jun 10, 2019	선재 김		5.240	Jun 13, 2019 @ 5.240	0.00%
Jun 10, 2019	명숙 민		5.240	Jul 05, 2019 @ 5.270	+0.57%
May 23, 2019	Ленчик Мерк		4.911	Jun 14, 2019 @ 5.240	+6.70%
Apr 25, 2019	김 선일		5.858	May 17, 2019 @ 5.070	-13.45%
Apr 25, 2019	김 선일		6.050	Apr 25, 2019 @ 5.858	-3.17%
Apr 17, 2019	승우 이		6.165	May 10, 2019 @ 5.230	-15.17%
Apr 16, 2019	Avihai ben tovim		6.840	May 10, 2019 @ 5.230	-23.54%
Apr 16, 2019	Suzanne Lindgren		8.086	May 10, 2019 @ 5.230	-35.32%
Apr 16, 2019	davide garulli		8.327	May 10, 2019 @ 5.230	+37.19%
Apr 15, 2019	김 선일		4.963	Apr 23, 2019 @ 6.240	+25.73%
Apr 15, 2019	김 선일		4.970	Apr 15, 2019 @ 4.963	-0.14%
Apr 15, 2019	김 선일		5.020	Apr 15, 2019 @ 4.970	-1.00%
Apr 15, 2019	김 선일		5.020	Apr 15, 2019 @ 5.020	0.00%
Apr 15, 2019	김 선일		5.040	Apr 15, 2019 @ 5.020	-0.40%
Apr 15, 2019	김 선일		5.174	Apr 15, 2019 @ 5.160	-0.27%
Apr 15, 2019	Anders Davidsen		5.170	May 10, 2019 @ 5.230	+1.16%
Apr 15, 2019	김 선일		5.200	Apr 15, 2019 @ 5.174	-0.50%
Apr 11, 2019	Дмитрий Пав		5.480	May 03, 2019 @ 6.180	+12.77%
Apr 11, 2019	김 선일		5.240	Apr 15, 2019 @ 5.200	-0.76%
Apr 11, 2019	김 선일		0.454	Apr 11, 2019 @ 0.437	-3.74%
Apr 11, 2019	김 선일		0.460	Apr 11, 2019 @ 0.465	+1.09%
Apr 11, 2019	김 선일		0.471	Apr 11, 2019 @ 0.460	-2.34%
Apr 04, 2019	Rasti		6.820	Apr 26, 2019 @ 6.210	-8.94%
Mar 29, 2019	Ленчик Мерк		6.340	Apr 19, 2019 @ 6.240	-1.58%

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

OCUP Comments

Write your thoughts about Rexahn Pharma

Are you sure you want to delete this chart?

Post also to:

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Note7Creole Nov 25, 2021 7:59AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Nice

1 0

Joe Jordan Nov 25, 2021 12:39AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Analyst Matthew Caufield set a price target of $26 on the stock, outlining four reasons for doing so. The company's shares are currently 38% above Tuesday's close at $4.81 but initially rose to a high of $5.50. The first of the four reasons for the rating is Ocuphire's phase 3 MIRA-2 trial's positive topline results for Nyxol. The analyst said that it presents an "opportune timing to get into the name prior to further program validation," which it expects in the near term. He also said a key differentiation of using Nyxol was another positive for the stock, adding that Ocuphire's APX3330 treatment for diabetic retinopathy is undervalued. "With Ocuphire completing a reverse merger with legacy oncology platform Rexahn Pharmaceuticals, and listing on NASDAQ in November 2020, we maintain invest

2 0

Jun 30, 2021 8:17AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

BLIN is next MRIN

1 0

Mr Intolerant Mar 16, 2021 1:32PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

I like $12. Holding until then at least. Good company.

3 0

Dong ThreeThousand Mar 15, 2021 6:13AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Ocuphire Announces MIRA-2 Phase 3 Registration Trial for the Reversal of Mydriasis Meets Primary Endpoint

0 1

Joe Jordan Feb 20, 2021 2:07AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Any target price?

0 0

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="200999217">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="200999217" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="200999217" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="200999217">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
		</div>
    </div>
			</div>
			<div id="show-more-comments">
				<a class="showMoreComments block">
					<span class="arial_12 showArrowafter">Show more comments (<span class="js-amount"></span>)</span>
				</a>
			</div>
			<div id="show-more-replies">
				<a class="showMoreReplies block">
					<span class="arial_12 showArrowafter">Show more replies (<span class="js-amount"></span>)</span>
				</a>
			</div>

Are you sure you want to delete this chart?

Replace the attached chart with a new chart ?

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

	US 30	38,511.7	+8.0	+0.02%
	US 500	5,083.0	+12.5	+0.25%
	Dow Jones	38,503.69	+263.71	+0.69%
	S&P 500	5,070.55	+59.95	+1.20%
	Nasdaq	15,696.64	+245.34	+1.59%
	S&P 500 VIX	15.76	+0.07	+0.45%
	Dollar Index	105.675	+0.170	+0.16%

	Crude Oil WTI	83.38	+0.02	+0.02%
	Brent Oil	88.49	+0.07	+0.08%
	Natural Gas	2.113	+0.019	+0.91%
	Gold	2,334.30	-7.80	-0.33%
	Silver	27.310	-0.052	-0.19%
	Copper	4.4640	+0.0295	+0.67%
	US Soybeans	1,169.38	+2.38	+0.20%

	U.S. 10Y	4.623	+0.024	+0.52%
	U.S. 30Y	4.742	+0.019	+0.40%
	U.S. 5Y	4.655	+0.033	+0.71%
	U.S. 3M	5.434	+0.039	+0.72%
	US 10Y T-Note	107.89	-0.19	-0.17%
	Euro Bund	130.87	-0.09	-0.07%
	10-2 Yield Spread	-33.29	+3.21	+-8.79%

	Apple	166.82	+0.98	+0.59%
	Alphabet A	158.27	+1.99	+1.27%
	Tesla	144.61	+2.56	+1.80%
	Amazon.com	179.51	+2.29	+1.29%
	Netflix	577.51	+22.92	+4.13%
	Meta Platforms	495.77	+14.05	+2.92%
	Bank of America	38.37	+0.64	+1.70%

Recent Quotes

	Name	Price	Chg.	Chg. %
	REXN	1.810	0.000	0.00%

	Name	Last	Chg. %	Vol.
	TSLA	144.61	+1.80%	95.40M
	AMD	152.24	+2.42%	44.37M
	AAPL	166.82	+0.59%	43.55M
	NVDA	824.18	+3.65%	42.50M
	META	495.77	+2.92%	14.38M
	SMCI	761.86	+6.25%	8.19M
	BRKa	615,108	-0.35%	13.05K

	Name	Last	Chg. %	Vol.
	GL	75.84	+14.23%	9.30M
	GE	162.66	+8.30%	18.43M
	MDB	366.31	+7.69%	1.70M
	DHR	253.11	+7.21%	6.52M
	SMCI	761.86	+6.25%	8.19M
	KMB	136.00	+5.48%	5.67M
	NCLH	19.55	+5.47%	10.18M

	Name	Last	Chg. %	Vol.
	LKQ	41.65	-14.88%	9.64M
	MSCI	446.09	-13.41%	3.64M
	NUE	174.54	-8.92%	4.76M
	IVZ	14.58	-6.42%	10.98M
	WRB	79.08	-5.21%	3.95M
	PKG	170.88	-4.69%	1.44M
	FDS	420.01	-4.20%	354.14K